mevastatin has been researched along with squalestatin 1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C | 1 |
| Michikawa, M; Yanagisawa, K | 2 |
| Appelbaum, FR; Banker, DE; Li, HY; Willman, CL; Zager, RA | 1 |
| Das, S; Krzyzanowska, A; Pastar, I; Samuels, HH; Stojadinovic, O; Tomic-Canic, M; Vouthounis, C; Vukelic, S | 1 |
| Cappello, V; Francolini, M; Fratangeli, A; Linetti, A; Matteoli, M; Passafaro, M; Rosa, P; Taverna, E; Valnegri, P | 1 |
1 review(s) available for mevastatin and squalestatin 1
| Article | Year |
|---|---|
The Medicinal Chemistry of Dengue Virus.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship | 2016 |
5 other study(ies) available for mevastatin and squalestatin 1
| Article | Year |
|---|---|
Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.
Topics: 3T3 Cells; Acetates; Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Survival; Cerebral Cortex; Cholesterol; Embryo, Mammalian; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, VLDL; Lovastatin; Mevalonic Acid; Mice; Neurons; PC12 Cells; Rabbits; Rats; Rats, Sprague-Dawley; Squalene; Tricarboxylic Acids | 1999 |
Apolipoprotein E4 isoform-specific actions on neuronal cells in culture.
Topics: Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Bridged Bicyclo Compounds, Heterocyclic; Cell Survival; Cells, Cultured; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, VLDL; Lovastatin; Male; Neurons; Protein Isoforms; Rabbits; Rats; Rats, Sprague-Dawley; Tricarboxylic Acids | 1999 |
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Cells; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Cytarabine; Daunorubicin; Drug Synergism; HL-60 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukemia, Myeloid; Lipoproteins, LDL; Lovastatin; Membrane Lipids; Protein Prenylation; Protein Processing, Post-Translational; Radiation-Sensitizing Agents; Tricarboxylic Acids; Tumor Cells, Cultured | 2003 |
Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cattle; Cell Line; Cell Movement; Enzyme Inhibitors; Epithelial Cells; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression Regulation; Glucocorticoids; Humans; Keratin-6; Keratinocytes; Ligands; Lovastatin; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Receptors, Glucocorticoid; Sesquiterpenes; Signal Transduction; Tricarboxylic Acids; Wound Healing | 2010 |
Cholesterol reduction impairs exocytosis of synaptic vesicles.
Topics: Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channels, N-Type; Cells, Cultured; Cholesterol; Exocytosis; Fumonisins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Lovastatin; Membrane Microdomains; Microscopy, Electron, Transmission; Models, Neurological; Neurons; Presynaptic Terminals; Rats; SNARE Proteins; Sphingolipids; Synaptic Vesicles; Synaptotagmin I; Tricarboxylic Acids | 2010 |